The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview
Open Access
- 21 January 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (3), 720
- https://doi.org/10.3390/ijms21030720
Abstract
Nevoid basal cell carcinoma syndrome (NBCCS), also named Gorlin syndrome, is a rare multisystem genetic disorder characterized by marked predisposition to basal cell carcinomas (BCCs), childhood medulloblastomas, maxillary keratocysts, celebral calcifications, in addition to various skeletal and soft tissue developmental abnormalities. Mutations in the tumor suppressor gene PATCHED1 (PTCH1) have been found to be associated in the majority of NBCCS cases. PATCH1 somatic mutations and loss of heterozygosity are also very frequent in sporadic BCCs. Unlike non-syndromic patients, NBCCS patients develop multiple BCCs in sun-protected skin area starting from early adulthood. Recent studies suggest that dermo/epidermal interaction could be implicated in BCC predisposition. According to this idea, NBCCS fibroblasts, sharing with keratinocytes the same PTCH1 germline mutation and consequent constitutive activation of the Hh pathway, display features of carcinoma-associated fibroblasts (CAF). This phenotypic traits include the overexpression of growth factors, specific microRNAs profile, modification of extracellular matrix and basement membrane composition, increased cytokines and pro-angiogenic factors secretion, and a complex alteration of the Wnt/β-catenin pathway. Here, we review studies about the involvement of dermal fibroblasts in BCC predisposition of Gorlin syndrome patients. Further, we matched the emerged NBCCS fibroblast profile to those of CAF to compare the impact of cell autonomous “pre-activated state” due to PTCH1 mutations to those of skin tumor stroma.Keywords
This publication has 114 references indexed in Scilit:
- Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer CellsPLOS ONE, 2013
- Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of SmoothenedClinical Cancer Research, 2011
- Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- PTCH1+/− Dermal Fibroblasts Isolated from Healthy Skin of Gorlin Syndrome Patients Exhibit Features of Carcinoma Associated FibroblastsPLOS ONE, 2009
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN PathwayCancer Research, 2009
- Nevoid basal cell carcinoma syndrome (Gorlin syndrome)Orphanet Journal of Rare Diseases, 2008
- Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndromeJournal of Medical Genetics, 2005
- smoothened encodes a receptor-like serpentine protein required for hedgehog signallingNature, 1996
- Role of the Drosophila patched gene in positional signallingNature, 1991